Table 3.
Patients’ characteristics at last follow-up (n = 20).
| Parameter | Absolute Frequency (%) | p Value | ||
|---|---|---|---|---|
| No Nephropathy | Nephropathy | |||
| Gender | Male | 4 (20) | 4 (20) | 0.714 |
| Female | 5 (25) | 7 (35) | ||
| DST | No | 4 (20) | 2 (10) | 0.336 |
| Yes | 5 (25) | 9 (45) | ||
| ACEI | No | 8 (40) | 1 (5) | 0.001 |
| Yes | 1 (5) | 10 (50) | ||
| Diabetes | No | 8 (40) | 8 (40) | 0.591 |
| Yes | 1 (5) | 3 (15) | ||
| Parameter | Median (25–75%) | p Value | ||
| No Nephropathy | Nephropathy | |||
| Age (years) | 32.0 (27.3–48.8) | 58.9 (47.9–65.8) | 0.001 | |
| UPCR (g/mol) | 9.60 (8.25–10.9) | 32.2 (12.2–95.2) * | 0.001 | |
| UACR (g/mol) | 0.85 (0.60–1.55) * | 7.80 (2.35–81.5) ** | 0.001 | |
| D-prot (g/day) | 0.11 (0.09–0.16) | 0.20 (0.14–1.41) | 0.067 | |
| S-Cr (µmol/L) | 63.0 (55.5–72.5) | 80.0 (58.0–87.0) | 0.175 | |
| U-Cr (µmol/L) | 5489 (3180–9601) * | 5441 (3247–10,802) | 0.657 | |
| eGFR (mL/min/1.73 m2) | 116.0 (99.5–119.5) | 81.0 (64.0–95.0) | 0.001 | |
| GFR slope (mL/min/year) | −0.71 (−2.30–1.87) | −2.17 (−4.34–−1.28) | 0.080 | |
DST, disease specific therapy; ACEI, angiotensin-converting enzyme inhibitor; UPCR, urinary protein-to-creatinine ratio; UACR, urinary albumin-to-creatinine ratio; D-prot, daily proteinuria; S-Cr, serum creatinine; U-Cr, urinary creatinine; eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate. Bold font indicates statistical significance. * One datum is missing. ** Two data are missing.